5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 7.00▲ | 7.01▲ | 7.11▼ | 6.69▲ | 7.16▼ |
MA10 | 6.99▲ | 7.14▼ | 6.93▲ | 6.86▲ | 6.39▲ |
MA20 | 7.10▼ | 6.87▲ | 6.64▲ | 7.13▼ | 5.98▲ |
MA50 | 6.87▲ | 6.65▲ | 6.80▲ | 6.26▲ | 7.70▼ |
MA100 | 6.63▲ | 6.86▲ | 7.34▼ | 5.89▲ | 7.66▼ |
MA200 | 6.78▲ | 7.32▼ | 6.64▲ | 7.24▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.030▼ | -0.004▼ | 0.080▲ | -0.127▼ | 0.267▲ |
RSI | 50.993▲ | 55.506▲ | 55.247▲ | 54.221▲ | 53.328▲ |
STOCH | 43.822 | 41.861 | 79.706 | 22.028 | 53.497 |
WILL %R | -72.000 | -37.895 | -27.273 | -60.703 | -49.487 |
CCI | -26.076 | -12.511 | 51.625 | -26.662 | 74.750 |
Monday, March 08, 2021 09:20 AM
Wall St. is looking at some big analyst calls that we have seen so far on Monday. We have included the most recent analyst call on each stock, as well as a recent trading history and the consensus ...
|
Monday, March 08, 2021 04:07 AM
Lead Compound AVB-500 Now Being Evaluated in Broad Range of CancersHOUSTON, March 08, 2021 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage oncology company developing transformative ...
|
Tuesday, March 02, 2021 04:22 AM
HOUSTON, March 02, 2021 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage oncology company developing transformative therapeutics, today announced that the Company will present ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
08/03/21 | 7.30 | 7.38 | 6.76 | 7.02 | 423,700 |
05/03/21 | 6.64 | 6.70 | 6.0101 | 6.46 | 224,724 |
04/03/21 | 6.61 | 6.66 | 6.19 | 6.52 | 199,018 |
03/03/21 | 6.75 | 6.98 | 6.56 | 6.68 | 93,779 |
02/03/21 | 6.91 | 7.00 | 6.70 | 6.79 | 101,382 |
01/03/21 | 7.00 | 7.45 | 6.84 | 6.85 | 136,340 |
26/02/21 | 7.00 | 7.24 | 6.64 | 6.81 | 125,181 |
25/02/21 | 7.30 | 7.4189 | 6.91 | 7.11 | 109,545 |
24/02/21 | 7.0126 | 7.6899 | 6.96 | 7.34 | 94,177 |
23/02/21 | 7.59 | 7.70 | 6.59 | 7.02 | 252,567 |
|
|
||||
|
|
||||
|
|